Preferred Care Partners Medicare Advantage Special Needs Plans (SNPs) are HMO and HMO-POS plans in Miami-Dade, Broward and Palm Beach counties. These plans combine the hospital and doctor coverage of Medicare Parts A and B with Part D prescription drug coverage, plus additional benefits and services designed to meet the unique needs of identified Medicare consumer populations.
Preferred Care Partners Dual Eligible SNP plans are intended for consumers eligible for Medicare & Medicaid benefits. These plans do not require referrals for specialty care.
The Preferred Care Partners Chronic Condition SNP plan provides specialized benefits and services for Medicare beneficiaries with chronic conditions such as diabetes, heart failure and/or cardiovascular disorders. This plan does not require referrals for specialty care.
Health Maintenance Organization (HMO) plans have a defined network of contracted local physicians and hospitals to provide member care. Generally, members must use these care providers to receive benefits for covered services, except in emergencies.
Point of Service (HMO-POS) plans include all the features of HMO plans plus the ability to go outside the contracted network for certain health care services - typically at a higher cost. Some POS plans only cover out-of-network dental care.
Preferred Care Partners is insured through UnitedHealthcare Insurance Company or one of its affiliated companies, a Medicare Advantage organization with a Medicare contract and a contract with the State Medicaid Program. Enrollment in the plan depends on the plan’s contract renewal with Medicare.
Coverage options may vary depending upon your location. To learn more about a plan in your service area, go to MyPreferredCare.com.
To learn more about Medicare Part D prescription drug coverage or to access related forms, please review the Prescription Drug Resources materials available on MyPreferredCare.com. This section contains information and forms for direct member reimbursement, medication prior authorization, and the prescription drug transition process.